ARCHIVES

Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research

This article is from The Cancer Letter archive.

Vol. 22 No. 44 | November 15, 1996

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011